Company Profile
Updated: 07-OCT-09GTC Biotherapeutics Inc.
Exporter
175 Crossing Blvd., Framingham, MA 01702-4476, United States
(508)620-9700, (508)370-3797 fax, http://www.gtc-bio.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Development of biotech pharmaceuticals for therapeutic uses. Services: Development and commercialization of therapeutic proteins in the milk of transgenic animals.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
LFB Provides $10 Million of Funding To GTC Biotherapeutics.
Biotech Week; 11/18/2009; 933 words; GTC Biotherapeutics, Inc. ("GTC", NASDAQ: GTCB) announced that LFB Biotechnologies, a...a further 3.4 million shares of common stock (see also GTC Biotherapeutics, Inc.). "LFB shares GTC's vision of being an innovative company...
Publication No. WO/2009/134389 Published on Nov. 5, Assigned to Gtc Biotherapeutics for Antibody (American Inventors)
US Fed News Service, Including US State News; 11/9/2009; 366 words; ...anti-cd137 antibody as an agent in the treatment of inflammatory conditions. The patent has been assigned to Gtc Biotherapeutics, Inc., Framingham, Mass. According to an abstract posted by the World Intellectual Property Organization: "The...
Money briefs.(MONEY)
Telegram & Gazette (Worcester, MA); 11/7/2009; 969 words; COLUMN: Money briefs GTC cuts losses, jobs FRAMINGHAM - GTC Biotherapeutics Inc. cut third-quarter losses compared with the same...focuses on certain projects and conserves cash. GTC reported in a news release it is reducing its work...
GTC Biotherapeutics Reports Third Quarter 2009 Financial Results.(Financial report)
Business Wire; 11/6/2009; 1756 words; FRAMINGHAM, Mass. -- GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ: GTCB) total net loss for the...to quarter end. Conference Call Information GTC Biotherapeutics will discuss these results and its business...
www.Xtremepicks.Com: Xtremepicks Alerts November 6, 2009 : OPXT, UEIC, GTCB and TASR.
M2 Presswire; 11/6/2009; 1826 words; ...Inc. (NASDAQ: UEIC), GTC Biotherapeutics, Inc.'s (NASDAQ: GTCB...website atwww.uei.com. GTC Biotherapeutics, Inc.'s (NASDAQ: GTCB...Mass., Nov 06, 2009 -- GTC Biotherapeutics, Inc.'s ("GTC", NASDAQ...
Recent News Articles
- GTC Biotherapeutics Reports Launch of ATryn[R] in the U.S. by Lundbeck Inc.
Business Wire - May 06, 2009 - GTC Biotherapeutics, Inc. - Financial and Strategic Analysis Review.
M2 Presswire - May 06, 2009 - GTC pursuing legal action against LEO.(GTC Biotherapeutics Inc.)(Leo Pharmaceutical Products)(Brief article)
Pharma Marketletter - March 23, 2009 - GTC Biotherapeutics Inc-Detailed Product Pipeline.
M2 Presswire - March 15, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning